Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Abuckatatime who wrote (1528)	11/21/1998 2:21:00 PM
From: William Whitehead Jr.	Read Replies (1) \| Respond to of 2173

To all! I came across an interesting article this morning (Saturday) as part of my reading that stated in no uncertain terms the company is shopping for a partner to purchase its accumulated research which is said to be worth between $50 and $100 million. Even discounting this by a reasonable factor, this still translates into a share value of between $0.90 and $2.75 or so. Maybe that is why insiders were said to have been actively recently buying! Something to consider before quickly parting with any remaining stock. Whitey,